Foresite Capital Fund IV, L.P. - 31 Jan 2025 SCHEDULE 13G Report for Maze Therapeutics, Inc. Common Stock, par value $0.001 (MAZE)

Filing Manager
Foresite Capital Fund IV, L.P.
Reporting Manager
James Tananbaum
Security
Maze Therapeutics, Inc. Common Stock, par value $0.001
Symbol
MAZE
Shares outstanding
43,876,929 shares
Disclosed Ownership
2,457,108 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
07 Feb 2025, 16:01:09 UTC
Date of event
31 Jan 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Foresite Capital Fund IV, L.P. 4.8% 2,111,917 2,111,917 0 /s/ James Tananbaum James Tananbaum, Managing Member of the General Partner
Foresite Capital Management IV, LLC 4.8% 2,111,917 2,111,917 0 /s/ James Tananbaum James Tananbaum, Managing Member
Foresite Capital Fund V, L.P. 0.8% 345,191 345,191 0 /s/ James Tananbaum James Tananbaum, Managing Member of the General Partner
Foresite Capital Management V, LLC 0.8% 345,191 345,191 0 /s/ James Tananbaum James Tananbaum, Managing Member
James Tananbaum 5.6% 2,457,108 2,457,108 0 /s/ James Tananbaum James Tananbaum